These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 7706744

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
    Tardif M, Mery L, Brouchon L, Boulay F.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3534-45. PubMed ID: 8468487
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Overexpression of wild-type and catalytically inactive forms of GRK2 and GRK6 fails to alter the agonist-induced phosphorylation of the C5a receptor (CD88): evidence that GRK6 is autophosphorylated in COS-7 cells.
    Milcent MD, Christophe T, Rabiet MJ, Tardif M, Boulay F.
    Biochem Biophys Res Commun; 1999 May 27; 259(1):224-9. PubMed ID: 10334944
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. C5a as a model for chemotactic factor-stimulated tyrosine phosphorylation in the human neutrophil.
    Richard S, Farrell CA, Shaw AS, Showell HJ, Connelly PA.
    J Immunol; 1994 Mar 01; 152(5):2479-87. PubMed ID: 8133059
    [Abstract] [Full Text] [Related]

  • 8. The role of the ribosomal protein S19 C-terminus in Gi protein-dependent alternative activation of p38 MAP kinase via the C5a receptor in HMC-1 cells.
    Nishiura H, Tokita K, Li Y, Harada K, Woodruff TM, Taylor SM, Nsiama TK, Nishino N, Yamamoto T.
    Apoptosis; 2010 Aug 01; 15(8):966-81. PubMed ID: 20473571
    [Abstract] [Full Text] [Related]

  • 9. Signaling by hemolytically inactive C5b67, an agonist of polymorphonuclear leukocytes.
    Wang C, Gerard NP, Nicholson-Weller A.
    J Immunol; 1996 Jan 15; 156(2):786-92. PubMed ID: 8543834
    [Abstract] [Full Text] [Related]

  • 10. The human chemoattractant complement C5a receptor inhibits cyclic AMP accumulation through Gi and Gz proteins.
    Shum JK, Allen RA, Wong YH.
    Biochem Biophys Res Commun; 1995 Mar 08; 208(1):223-9. PubMed ID: 7887933
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation.
    Tomhave ED, Richardson RM, Didsbury JR, Menard L, Snyderman R, Ali H.
    J Immunol; 1994 Oct 01; 153(7):3267-75. PubMed ID: 8089498
    [Abstract] [Full Text] [Related]

  • 13. C5a stimulus-secretion coupling in rat basophilic leukaemia (RBL-2H3) cells transfected with the human C5a receptor is mediated by pertussis and cholera toxin-sensitive G proteins.
    Monk PN, Pease JE, Barker MD.
    Biochem Mol Biol Int; 1994 Jan 01; 32(1):13-20. PubMed ID: 8012277
    [Abstract] [Full Text] [Related]

  • 14. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
    Nilsson G, Johnell M, Hammer CH, Tiffany HL, Nilsson K, Metcalfe DD, Siegbahn A, Murphy PM.
    J Immunol; 1996 Aug 15; 157(4):1693-8. PubMed ID: 8759757
    [Abstract] [Full Text] [Related]

  • 15. Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes.
    Van Epps DE, Simpson S, Bender JG, Chenoweth DE.
    J Immunol; 1990 Feb 01; 144(3):1062-8. PubMed ID: 2295813
    [Abstract] [Full Text] [Related]

  • 16. Regulation of the human bradykinin B2 receptor expressed in sf21 insect cells: a possible role for tyrosine kinases.
    Reyes-Cruz G, Vázquez-Prado J, Müller-Esterl W, Vaca L.
    J Cell Biochem; 2000 Jan 01; 76(4):658-73. PubMed ID: 10653985
    [Abstract] [Full Text] [Related]

  • 17. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
    Schraufstatter IU, Discipio RG, Zhao M, Khaldoyanidi SK.
    J Immunol; 2009 Mar 15; 182(6):3827-36. PubMed ID: 19265162
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.